Abridge | Latest News & Updates - Mar 07, 2025 Release
Abridge's AI platform is being expanded by a leading global cancer center for oncology clinical documentation as of March 5, 2025...
Brought to you by RivalSense - an AI tool for monitoring any company.
RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡


Abridge
🌎 abridge.comAbridge is a healthcare technology company founded in 2018 that specializes in transforming patient-clinician conversations into structured clinical notes using generative AI. Their platform enhances clinical documentation efficiency, allowing clinicians to focus on patient care while ensuring accurate and auditable AI-generated summaries. Abridge integrates deeply with electronic medical records (EMR) systems, setting industry standards for the responsible use of AI in healthcare.
Abridge - Latest News and Updates
- Abridge's AI platform is being expanded by a leading global cancer center for oncology clinical documentation as of March 5, 2025.
- Abridge's platform for clinical conversations will be implemented at Memorial Sloan Kettering Cancer Center after a successful pilot through the MSK Innovation Hub program.
- Abridge has been adopted by MSK Cancer Center to enhance clinical conversations and patient care.
- Abridge recently announced a funding raise, generating significant discussion about ambient scribes and voice AI at ViVE.
- Madeline McKay has joined Abridge as Director of Enterprise, Commercial in the Dallas-Fort Worth Metroplex, previously serving as Account Executive at Concentra.
- Austin Smith has joined Abridge as Director Enterprise Development, Strategic Accounts, after serving as Strategic Account Executive at Get Well.
- Abridge is currently seeking a Director of Renewals in the United States.
- Abridge will showcase a demo of Abridge Inside Epic at booth #5152 during the HIMSS Global Health Conference & Exhibition.
- Shivdev Rao, CEO of Abridge, is recognized as one of TIME's most influential people in AI.
- Abridge CEO Shivdev Rao discussed the company's Contextual Reasoning Engine on a podcast with Scott Becker, highlighting its ability to generate real-time clinically useful and billable notes.
Sign up to receive regular updates
If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.
